880 related articles for article (PubMed ID: 31219699)
21. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.
Melchior B; Garcia AE; Hsiung BK; Lo KM; Doose JM; Thrash JC; Stalder AK; Staufenbiel M; Neumann H; Carson MJ
ASN Neuro; 2010 Jul; 2(3):e00037. PubMed ID: 20640189
[TBL] [Abstract][Full Text] [Related]
22. Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2.
Claes C; Van Den Daele J; Boon R; Schouteden S; Colombo A; Monasor LS; Fiers M; Ordovás L; Nami F; Bohrmann B; Tahirovic S; De Strooper B; Verfaillie CM
Alzheimers Dement; 2019 Mar; 15(3):453-464. PubMed ID: 30442540
[TBL] [Abstract][Full Text] [Related]
23. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
24. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
[TBL] [Abstract][Full Text] [Related]
25. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.
McQuade A; Kang YJ; Hasselmann J; Jairaman A; Sotelo A; Coburn M; Shabestari SK; Chadarevian JP; Fote G; Tu CH; Danhash E; Silva J; Martinez E; Cotman C; Prieto GA; Thompson LM; Steffan JS; Smith I; Davtyan H; Cahalan M; Cho H; Blurton-Jones M
Nat Commun; 2020 Oct; 11(1):5370. PubMed ID: 33097708
[TBL] [Abstract][Full Text] [Related]
26. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.
Shi Q; Chowdhury S; Ma R; Le KX; Hong S; Caldarone BJ; Stevens B; Lemere CA
Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566429
[TBL] [Abstract][Full Text] [Related]
27. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
[TBL] [Abstract][Full Text] [Related]
28. Sleep deprivation exacerbates microglial reactivity and Aβ deposition in a
Parhizkar S; Gent G; Chen Y; Rensing N; Gratuze M; Strout G; Sviben S; Tycksen E; Zhang Q; Gilmore PE; Sprung R; Malone J; Chen W; Remolina Serrano J; Bao X; Lee C; Wang C; Landsness E; Fitzpatrick J; Wong M; Townsend R; Colonna M; Schmidt RE; Holtzman DM
Sci Transl Med; 2023 Apr; 15(693):eade6285. PubMed ID: 37099634
[TBL] [Abstract][Full Text] [Related]
29. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway.
Ruganzu JB; Zheng Q; Wu X; He Y; Peng X; Jin H; Zhou J; Ma R; Ji S; Ma Y; Qian Y; Wang Y; Yang W
Exp Neurol; 2021 Feb; 336():113506. PubMed ID: 33065077
[TBL] [Abstract][Full Text] [Related]
30. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
[TBL] [Abstract][Full Text] [Related]
31. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
[TBL] [Abstract][Full Text] [Related]
32. Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.
Teter B; Morihara T; Lim GP; Chu T; Jones MR; Zuo X; Paul RM; Frautschy SA; Cole GM
Neurobiol Dis; 2019 Jul; 127():432-448. PubMed ID: 30951849
[TBL] [Abstract][Full Text] [Related]
33. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer's disease.
Ruganzu JB; Peng X; He Y; Wu X; Zheng Q; Ding B; Lin C; Guo H; Yang Z; Zhang X; Yang W
Mol Immunol; 2022 Feb; 142():22-36. PubMed ID: 34959070
[TBL] [Abstract][Full Text] [Related]
35. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
[TBL] [Abstract][Full Text] [Related]
36. Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2.
Ulrich JD; Finn MB; Wang Y; Shen A; Mahan TE; Jiang H; Stewart FR; Piccio L; Colonna M; Holtzman DM
Mol Neurodegener; 2014 Jun; 9():20. PubMed ID: 24893973
[TBL] [Abstract][Full Text] [Related]
37. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
[TBL] [Abstract][Full Text] [Related]
38. TREM1 facilitates microglial phagocytosis of amyloid beta.
Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT
Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763
[TBL] [Abstract][Full Text] [Related]
39. Fibrillar amyloid plaque formation precedes microglial activation.
Jung CK; Keppler K; Steinbach S; Blazquez-Llorca L; Herms J
PLoS One; 2015; 10(3):e0119768. PubMed ID: 25799372
[TBL] [Abstract][Full Text] [Related]
40. Long-term voluntary exercise inhibited AGE/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP/PS1 transgenic mice.
Wang YY; Zhou YN; Jiang L; Wang S; Zhu L; Zhang SS; Yang H; He Q; Liu L; Xie YH; Liang X; Tang J; Chao FL; Tang Y
Exp Neurol; 2023 May; 363():114371. PubMed ID: 36871860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
